Pruritus Visual Analog Scale (Pruritus VAS)
Pruritus Visual Analog Scale · Also known as: Itch VAS, Pruritus Severity Scale
The Pruritus Visual Analog Scale (VAS) is a simple, single-item patient-administered tool measuring itch intensity on a continuous 0–10 (or 0–100) scale. Adapted from the original VAS for pain, it is one of the most frequently used outcome measures in dermatological research and clinical practice due to its simplicity, brevity, and responsiveness to treatment. Pruritus VAS is essential in trials of antipruritic therapies and in conditions where itching is a primary complaint (atopic dermatitis, psoriasis, pruritus ani, lichen planus).
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Pruritus VAS is appropriate for any patient with skin disease, particularly those with pruritus as a primary or significant symptom (atopic dermatitis, urticaria, lichen planus, primary biliary cholangitis, pruritus ani). It should be used at baseline and at each follow-up visit to track treatment response. Frequent assessment (weekly or bi-weekly) is feasible due to the measure's brevity. Pruritus VAS is especially valuable in telemedicine settings where objective clinical examination is limited. In clinical trials, it is often used as a secondary efficacy endpoint alongside objective severity measures. For patients with chronic itching, repeated VAS assessment can help identify triggers and guide therapy adjustments.
Strengths & limitations
- Simplicity; single item, single question, requires no training or clinician input.
- Brevity; administration takes seconds; very low respondent burden.
- Universality; language-free; visual format accessible to illiterate and multilingual populations.
- Responsiveness; sensitive to small changes in itch intensity; responsive to antipruritic treatments.
- Continuity; yields a continuous score (not ordinal categories), enabling fine-grained assessment of change.
- Validated extensively in dermatological and non-dermatological conditions.
- Suitable for frequent assessment; daily or weekly completion is feasible.
- Electronic versions available; compatible with telemedicine, mHealth apps, and electronic health records.
- Subjectivity; entirely patient-reported; vulnerable to recall bias, mood, and day-to-day fluctuation.
- No dimension capture; does not distinguish between itch frequency, duration, or impact; a patient with itching 1 hour daily at intensity 5 vs. 8 hours daily at intensity 5 would report the same VAS at the moment of assessment.
- Anchor ambiguity; interpretation of 'worst possible itching' is variable across individuals; some patients may not use the full 0–10 scale.
- Single-item limitation; vulnerable to measurement error; no internal consistency checks.
- Does not capture quality-of-life impact directly; high VAS may correlate poorly with functioning in some patients.
- Recall period variability; if assessment is of 'current' vs. 'past 7 days' itch, scores may differ substantially.
- Ceiling and floor effects possible in populations with very mild or very severe disease.
Frequently asked
Should Pruritus VAS be combined with objective severity measures like PASI or EASI?
Yes. Pruritus VAS captures subjective itch burden, while objective measures capture disease extent and sign intensity. They do not correlate perfectly; a patient may have mild objective disease but severe itching. Use both together: objective measures for clinical trial efficacy assessment and pruritus VAS for symptom burden and patient-centered benefit.
What is the MCID for Pruritus VAS?
A change of ≥2 points on the 0–10 scale (or ≥20 on the 0–100 scale) is considered clinically significant improvement. However, in patients with very high baseline itch (8–10), a reduction of ≥3 points may be more meaningful. Always report absolute change and percentage change from baseline for contextualization.
How should I handle variability in daily pruritus scores?
Pruritus naturally fluctuates with time of day, stress, temperature, and activity. To reduce variability, standardize assessment: always measure at the same time of day (e.g., morning before activity, or evening before bed), ask specifically about itch over the past 24 hours or past week (not current moment), and assess at consistent intervals (weekly, bi-weekly). Alternatively, calculate the mean of multiple assessments (e.g., twice weekly) to smooth variability.
Can Pruritus VAS be self-administered at home?
Yes. For paper versions, patients can mark a line at home and bring it to clinic, or photograph it for remote documentation. Digital versions (smartphone apps, web forms) enable real-time submission. Ensure clear written instructions and consistent administration format to minimize error.
Is Pruritus VAS suitable for children?
Yes, from age 4–5 years onward; children can understand and mark a scale representing itch severity. For younger children (under 4), pictorial scales (faces ranging from happy to sad) may be more appropriate. Always verify understanding before administration.
Sources
- Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162(3):587-593. DOI: 10.1111/j.1365-2133.2009.09586.x ↗
- Huskisson EC. Visual analog scales. In: Melzack R, ed. Pain Measurement and Assessment. New York: Raven Press; 1983:33-37. link ↗
How to cite this page
ScholarGate. (2026, June 3). Pruritus Visual Analog Scale. ScholarGate. https://scholargate.app/en/dermatology/pruritus-visual-analog-scale
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
Compare side by side →